These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27559692)
1. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma. Papaseit E; Farré M; Graziano S; Pacifici R; Pérez-Mañá C; García-Algar O; Pichini S Clin Chem Lab Med; 2017 Mar; 55(3):415-423. PubMed ID: 27559692 [TBL] [Abstract][Full Text] [Related]
2. Identification and quantification of nicotine biomarkers in human oral fluid from individuals receiving low-dose transdermal nicotine: a preliminary study. Miller EI; Norris HR; Rollins DE; Tiffany ST; Moore CM; Vincent MJ; Agrawal A; Wilkins DG J Anal Toxicol; 2010 Sep; 34(7):357-66. PubMed ID: 20822672 [TBL] [Abstract][Full Text] [Related]
3. Assessment of local tobacco consumption by liquid chromatography-tandem mass spectrometry sewage analysis of nicotine and its metabolites, cotinine and trans-3'-hydroxycotinine, after enzymatic deconjugation. Rodríguez-Álvarez T; Rodil R; Rico M; Cela R; Quintana JB Anal Chem; 2014 Oct; 86(20):10274-81. PubMed ID: 25263812 [TBL] [Abstract][Full Text] [Related]
4. Successful Nicotine Intake in Medical Assisted Use of E-Cigarettes: A Pilot Study. Pacifici R; Pichini S; Graziano S; Pellegrini M; Massaro G; Beatrice F Int J Environ Res Public Health; 2015 Jul; 12(7):7638-46. PubMed ID: 26184244 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry. Vieira-Brock PL; Miller EI; Nielsen SM; Fleckenstein AE; Wilkins DG J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3465-74. PubMed ID: 21963483 [TBL] [Abstract][Full Text] [Related]
6. Assessment of nicotine delivery and uptake in users of various tobacco/nicotine products. Scherer G; Mütze J; Pluym N; Scherer M Curr Res Toxicol; 2022; 3():100067. PubMed ID: 35330709 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Adriaens K; Van Gucht D; Declerck P; Baeyens F Int J Environ Res Public Health; 2014 Oct; 11(11):11220-48. PubMed ID: 25358095 [TBL] [Abstract][Full Text] [Related]
8. Cigarettes vs. e-cigarettes: Passive exposure at home measured by means of airborne marker and biomarkers. Ballbè M; Martínez-Sánchez JM; Sureda X; Fu M; Pérez-Ortuño R; Pascual JA; Saltó E; Fernández E Environ Res; 2014 Nov; 135():76-80. PubMed ID: 25262078 [TBL] [Abstract][Full Text] [Related]
9. Levels of saliva cotinine in electronic cigarette users. Etter JF Addiction; 2014 May; 109(5):825-9. PubMed ID: 24401004 [TBL] [Abstract][Full Text] [Related]
10. Oral fluid nicotine markers to assess smoking status and recency of use. Scheidweiler KB; Marrone GF; Shakleya DM; Singleton EG; Heishman SJ; Huestis MA Ther Drug Monit; 2011 Oct; 33(5):609-18. PubMed ID: 21860341 [TBL] [Abstract][Full Text] [Related]
11. Measurement of nicotine, cotinine and trans-3'-hydroxycotinine in meconium by liquid chromatography-tandem mass spectrometry. Xia Y; Xu M; Alexander RR; Bernert JT J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2142-8. PubMed ID: 21689995 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of nicotine, cotinine, norcotinine, and trans-3'-hydroxycotinine in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. Kim I; Darwin WD; Huestis MA J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):233-40. PubMed ID: 15639444 [TBL] [Abstract][Full Text] [Related]
13. Abuse liability assessment of an electronic cigarette in combustible cigarette smokers. Maloney SF; Breland A; Soule EK; Hiler M; Ramôa C; Lipato T; Eissenberg T Exp Clin Psychopharmacol; 2019 Oct; 27(5):443-454. PubMed ID: 30777773 [TBL] [Abstract][Full Text] [Related]
14. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice. Ponzoni L; Moretti M; Sala M; Fasoli F; Mucchietto V; Lucini V; Cannazza G; Gallesi G; Castellana CN; Clementi F; Zoli M; Gotti C; Braida D Eur Neuropsychopharmacol; 2015 Oct; 25(10):1775-86. PubMed ID: 26141510 [TBL] [Abstract][Full Text] [Related]
15. Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo. Kanamori K; Ahmad SM; Shin CS; Hamid A; Lutfy K Drug Metab Dispos; 2022 Dec; 50(12):1454-1463. PubMed ID: 36184079 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of nicotine and its metabolites I. Model development. Levi M; Dempsey DA; Benowitz NL; Sheiner LB J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):5-21. PubMed ID: 17206524 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of tobacco alkaloids and major phase I metabolites by LC-MS/MS in human tissue. Fischer L; Mikus F; Jantos R; Skopp G Int J Legal Med; 2015 Mar; 129(2):279-87. PubMed ID: 25304849 [TBL] [Abstract][Full Text] [Related]
19. Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players. Marclay F; Saugy M J Chromatogr A; 2010 Nov; 1217(48):7528-38. PubMed ID: 20980010 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients. Landmesser A; Scherer M; Pluym N; Sarkar M; Edmiston J; Niessner R; Scherer G Nicotine Tob Res; 2019 Feb; 21(3):314-322. PubMed ID: 30265341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]